Nordson(US:NDSN) ZACKS·2024-08-21 23:00Core Insights - Nordson reported revenue of $661.6 million for the quarter ended July 2024, reflecting a 2% increase year-over-year and surpassing the Zacks Consensus Estimate of $655.23 million by 0.97% [1] - The company's EPS for the quarter was $2.41, up from $2.35 in the same quarter last year, exceeding the consensus EPS estimate of $2.33 by 3.43% [1] Revenue Performance - Net Sales for Industrial Precision Solutions reached $370.56 million, exceeding the average estimate of $366.66 million by analysts, marking a year-over-year increase of 9.6% [3] - Net Sales for Advanced Technology Solutions were reported at $124.31 million, surpassing the average estimate of $117.31 million, but showing a decline of 10.9% compared to the previous year [4] - Net Sales for Medical and Fluid Solutions amounted to $166.74 million, below the average estimate of $172.65 million, representing a year-over-year decrease of 2.4% [5] Operating Profit Analysis - Operating profit for Advanced Technology Solutions was $22.95 million, exceeding the average estimate of $19.99 million [6] - Operating profit for Medical and Fluid Solutions was $48.37 million, falling short of the average estimate of $50.71 million [6] - Operating profit for Industrial Precision Solutions was $118.11 million, slightly below the average estimate of $118.95 million [7] - Corporate operating loss was reported at -$22.37 million, worse than the average estimate of -$18.50 million [8] Stock Performance - Over the past month, Nordson's shares have returned -0.2%, in contrast to the Zacks S&P 500 composite's increase of 1.8% [8] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [8]